Congenital diaphragmatic hernia is a rare disease associated with high mortality and morbidity. Antenatal ultrasound screening identifies more than 70% of cases, providing the opportunity for in utero referral to a tertiary care center for expert assessment and perinatal management. Additional genetic and morphologic assessment may be used to rule out associated anomalies. In isolated cases, the outcome may be predicted prenatally by medical imaging. The combination of lung size and liver herniation is a widely accepted method to stratify fetuses into groups with an increasing degree of pulmonary hypoplasia and corresponding mortality rates. Ultrasound measurement of the observed to expected lung-to-head ratio (o/e LHR) is most widely used. The o/ e LHR is an independent predictor of survival and short-term morbidity. Finally, evaluation of stomach position has recently been introduced as an indirect method to estimate severity of the disease in left-sided defects, as it has been shown to correlate with the proportion of intrathoracic liver. Herein, we propose a protocol for the standardized ultrasound assessment of fetuses with isolated CDH and individualized prediction of neonatal outcome.
| INTRODUCTION
Between 5000 and 8000 rare diseases affect the daily lives of around 30 million people in the European Union. 1 The European Commission supports the European Member States by pooling knowledge and expertise, registries, data, and funding for the management of these rare diseases. A more recent initiative is the establishment of European reference networks (ERNs). European reference networks are virtual thematic networks involving health care providers across Europe. They aim to tackle complex or rare diseases and conditions that require highly specialized treatment and concentrated knowledge and resources. Health systems in the European Union aim to provide high-quality, cost-effective care that is accessible. This is particularly difficult with rare or low-prevalence complex diseases or conditions.
To review a patient's diagnosis and treatment, health care providers/ members of an ERN will consult, exchange information and share knowledge with other members of the network. Coordinators and other networks leaders convene for that purpose "virtual" advisory boards of medical specialists across different disciplines, and dedicated IT platform and telemedicine tools will be made widely available.
One of their tasks is to develop practical guides and share their knowledge with other health care workers and patients.
"ERNICA" is the ERN on rare diseases of the foregut grouping skills from 20 centers in 11 countries. It covers malformations of the digestive system, the diaphragm, and abdominal wall. Congenital diaphragmatic hernia (CDH) occurs in approximatively 1/2500 newborns;
hence, it is a rare disease (ORPHA: 2140). In most cases, it is left sided (85%). Thirteen percent of cases are right sided, while other locations and forms are very rare. 2, 3 In around 40% of cases, CDH is not the only problem (Table 1) , and outcome is codetermined by the severity of associated conditions. 4 These need therefore to be ruled out prenatally by advanced genetic testing and when applicable additional imaging.
Isolated CDH is associated with significant neonatal mortality and morbidity, which are primarily due to pulmonary hypoplasia and persistent pulmonary hypertension. 5 The neonatal period is critical to CDH babies, yet the spectrum of respiratory and hemodynamic problems among CDH infants may range from mild respiratory symptoms to severe respiratory and hemodynamic failure leading to early neonatal death. Therefore, antenatal prediction of individual disease severity is desirable to counsel parents, but also to discuss the potential of antenatal management of the condition, such as termination of pregnancy and fetal therapy, which today is available within the framework of clinical trials. 6 In line with one of the generic objectives of the ERN, we aim to provide a practical and instructional guide for the standard- 
| LUNG SIZE
The lung-to-head ratio (LHR), first described by Metkus et al, 10 provides an indirect estimate of the size of the lung contralateral to the hernia normalized for the head circumference. It is based on a standardized measurement in a 2-dimensional plane. It was initially used in the late second trimester and values under 1.0 were considered predictive of poor outcome. However, the LHR changes over gestation as the lung area grows more rapidly than the head circumference. Therefore, the observed to expected (o/e) LHR was introduced to eliminate the effect of gestational age (GA) at assessment. 11 The o/e LHR has been shown to be an independent predictor of postnatal survival 11 both in left-and right-sided CDH, and to some short-term morbidity indicators. [12] [13] [14] The o/e LHR is now widely accepted as a prenatal tool to counsel parents on outcome and is used to select patients for fetal therapy trials, including the TOTAL trial. 6 Other ultrasound methods to assess lung size, such as the lung-tothorax ratio, 15 the quantitative lung index, 16 and 3-dimensional measurements of lung volume, 17 have also been proposed, but they are less validated hence not discussed in here. Lungs can also be measured with fetal MRI, which will be briefly discussed in the following section, yet, again, falls beyond the scope of this paper. 18 1 The lung contralateral to the CDH is measured in an axial plane at the level of the 4-chamber view of the heart. To obtain the most accurate measurement, the lung is ideally close to the ultrasound transducer ( Figure 1A ,B; Online supporting information: Video S1).
| Practical points
2 To avoid shadowing, the transducer should be parallel to the fetal ribs, and therefore, a maximum of 2 ribs should be visible.
3 The contralateral lung area is measured using the tracing method, which allows an accurate area estimation even if the lung shape is irregular ( Figure 2A ). 19 Also, the longest axis methods is being used, with its own reference values (Online supporting information: Video S2). The anterior-posterior diameter method is the least reproducible and should therefore not be used. Central nervous system abnormalities (1-10%)
Neural tube defects; Hydrocephalus; Corpus callosum agenesis (rare).
Musculoskeletal anomalies (1-15%)
Polydactyly; Syndactyly; Limb reduction defects.
Gastro-intestinal malformations (2-10%)
Malrotation/atresia; Omphalocele; Situs ambiguous.
Chest anomalies (2-5%) Bronchopulmonary sequestration; Congenital pulmonary airway malformation.
What's already known about this topic?
• Congenital diaphragmatic hernia is associated with high postnatal mortality and morbidity.
• Prenatal diagnosis is often possible with ultrasound, after which patients are referred to specialized centers.
• In isolated cases, antenatal ultrasound allows prediction of outcome.
What does this study add?
• ) when using this tracing method. This formula is based on data from a large normative study on normal fetuses. 19 An automated calculator of the o/e LHR can be found on www.totaltrial.eu.
| LIVER POSITION
Liver herniation into the thorax has first been suggested as a predictive measure by Harrison et al. 20 According to some studies, in leftsided cases, this factor is an independent predictor next to lung size (as o/e LHR). 21, 22 Although it is theoretically possible to quantify with ultrasound the amount of liver into the thorax, liver position on ultrasound is usually used as binary variable, hence, either "up" (in the thorax) or "down" (confined to the abdomen). As the echogenicity of the liver is very similar to that of the lung, it can be difficult to assess the Ultrasound section at the level of the 4-chamber view for measurement of the lung area. A, The lung is close to the probe and its contours are easily determined. B, In this case, the lung is posterior and shadows from other thoracic organs do not allow precise delineation of the pulmonary area liver position or its extent into the thorax. Liver herniation can be determined both for left-and right-sided CDH, though in the latter case, the liver is nearly always herniating through the defect. For that reason, it has no predictive value in right-sided CDH. 1 Doppler interrogation of the hepatic vessels in a longitudinal or coronal plane: visualization of these vessels coursing up above the diaphragmatic edge is diagnostic for liver herniation 10 ( Figure 3B ).
2 Visualization of the ductus venosus and the gallbladder: the presence of any of these structures into the thorax is diagnostic for liver herniation. 25 Liver herniation is also suspected when these organs are ectopically located in the abdomen ( Figure 3C ). CDH, as it has been shown to correlate with the proportion of intrathoracic liver determined by MRI. 27 In several case series, the exact position of the stomach into the chest has been shown to correlate with postnatal mortality and morbidity independent from the o/e LHR.
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| Practical points
Stomach position is evaluated in an axial plane at the level of the 4-chamber view, hence, similar to the section used for measuring the lung area.
Stomach position is categorized as follows:
• Grade 1 or abdominal: the stomach is in its normal position hence not visualized in the chest ( Figure 4A ).
• Grade 2 or anterior left in the chest: the stomach is visualized anteriorly at the apex of the heart, in contact with the anterior chest wall ( Figure 4B ).
FIGURE 3
Ultrasound evidence of liver herniation in left-sided congenital diaphragmatic hernia (CDH) cases. A, Sagittal section of the fetal abdomen and thorax demonstrating liver herniation (L). B, Visualization of the hepatic vessels above the diaphragmatic edge (arrow). C, The gallbladder (arrow) is identified as a Doppler-negative, anechoic structure inside the liver. As a consequence of the herniation and rotation of the liver, the gallbladder is visualized on the left side of the abdomen. D, Bowing of the umbilical segment of the portal vein towards the left side (arrow); the same section from a CDH fetus without liver herniation is provided on the right for comparison
• Grade 3 or mid-to-posterior left chest: the stomach is not in contact with the anterior left chest wall; yet next to the atrial-ventricular heart valves but with its larger part still anterior ( Figure 4C ).
• Grade 4 or retrocardiac: most of the stomach is located posterior to atrial-ventricular valves, next to the left atrium of the heart within the right chest ( Figure 4D ).
In clinical practice both the liver position and the o/e LHR are used to stratify patients. The other most commonly observed malformations are summarized inTable 1. Finally, intrafetal fluid effusions are a relatively common ultrasound finding in CDH fetuses, observed in up to 5% and 29% of left-and right-sided CDH cases, respectively. 39 Such effusions could be related to liver congestion due to hepatic venous kinking, or to bowel irritation. 40 However, it has been shown that CDH fetuses with associated pleural effusion/ascites have the same postnatal outcome as those with isolated CDH without those effusions. 39 Effusions also often are meeting the criteria for "hydrops" (ie, effusions in 2 or more fetal compartments). However, fetal hydrops in CDH fetuses may not have the same dismal prognosis as in fetuses with hydrops due to other causes 
Fetal MRI
Fetal MRI is widely used in the evaluation of fetal lung pathologies including CDH and is currently the referral technique for fetal lung volume estimation. 42 Magnetic resonance imaging provides a more reliable measurement of both the lungs contralateral and ipsilateral to the defect than ultrasound does. However, the relative contribution of the ipsilateral lung to the total fetal lung volume is probably small in cases with worse prognosis. 43 The most used formula for the observed-to-expected total lung volume is the one reported by Gorincour et al, however, accuracy can be increased by referring to an expected value through matching on fetal body volume. 44, 45 Magnetic resonance imaging also allows a good estimate of liver herniation (liver thoracic ratio), 46 yet also for that several methods have been proposed. In general, the clinical reality is that access to ultrasound is easier for patients. Therefore, we propose in this document that patients should be at least offered a comprehensive ultrasound assessment as described above, which will allow to estimate severity.
Genetic testing
Genetic testing should complete the diagnostic evaluation and is mandatory in case of prenatal therapy. A causative cytogenetic aberration is detected in 2% to 33% of patients with CDH. [47] [48] [49] [50] The largest array comparative genomic hybridization study on 256 CDH patients found chromosome/subchromosome abnormalities in 6.3% of affected individuals. 47 Cytogenetic abnormalities related to CDH have been detected in almost every chromosome arm, and recurrent aberrations have provided information about the postulated locations of CDHcausing genes. 49, 50 Many of the most common chromosome aberrations (Table 2) are diagnosable with a conventional karyotype. However, array comparative genomic hybridization offers an incremental yield over conventional karyotyping as it allows detection of small genomic deletions and duplications that are clinically relevant in some CDH cases (Table 2) . Search for specific mutations leading to recognized syndromes is also recommended in case of multiple anomalies.
However, a specific cytogenetic anomaly has not yet been recognized in all CDH-associated syndromes. For a more detailed overview on genetic anomalies associated to CDH, we refer to the excellent reviews by Slavotinek 65 and Kardon and Ackerman. 66 
| CONCLUSION
Accurate prenatal assessment of a fetus with CDH and individualized prognostic assessment requires a comprehensive assessment by physicians familiar with the condition. Evaluation may not be easy and be very operator dependent. For instance, the learning curve for accurate measurement of the LHR was shown to be long (72-77 measurements). 67 Also, operators with different experience levels may disagree on critical parameters such as liver position and o/e LHR in a significant number of cases. 68 A recent multicenter study has shown that the predictive value of the o/e LHR is higher in centers with greater caseloads. 69 Therefore, it may be wise to refer patients for prenatal assessment to centers with experience with prenatal assessment and management of fetuses with CDH. In isolated cases, the combination of liver herniation and o/e LHR is a widely accepted method to stratify fetuses with left-and right-sided CDH into groups with an increasing degree of pulmonary hypoplasia and corresponding mortality rates. It is also used to select patients for fetal therapy trials.
